⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL21058276 | 0.97 | ALOX15 (0.40) | — | |
| SCHEMBL8002665 | 0.84 | ELANE (0.36) | — | |
| SCHEMBL30753033 | 0.83 | — | — | |
| SCHEMBL29665190 | 0.82 | HPGD (0.37) | — | |
| SCHEMBL29665186 | 0.82 | HPGD (0.37) | — | |
| SCHEMBL23786781 | 0.81 | ALOX15 (0.36) | — | |
| SCHEMBL29519111 | 0.81 | TSHR (0.44) | — | |
| Aniline SCHEMBL28104782 | 0.81 | MAPT (0.39) | — | |
| SCHEMBL23072785 | 0.80 | ALDH1A1 (0.36) | — | |
| SCHEMBL224525 | 0.80 | LMNA (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3639 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118018-A | Tumor targeting photo-thermal reagent based on fluorenyl rhodamine and preparation method and application thereof | 山西大学 | 2025-06-10 | — | — | CN | claimed |
| CN-118388904-B | Low-smoke-release and incombustible perfluororubber foam composition, foam and preparation method thereof | 上海芯密科技股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| US-12060334-B2 | 3-substituted phenazine derivatives as antimicrobial agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-08-13 | — | — | US | claimed |
| CN-117551326-B | Foamable composition based on perfluororubber and preparation method thereof | 上海芯密科技有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-118388904-A | Low-smoke-release and incombustible perfluororubber foam composition, foam and preparation method thereof | 上海芯密科技有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-117551326-A | Foamable composition based on perfluororubber and preparation method thereof | 上海芯密科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| EP-3715346-B1 | THIAZOLYL-CONTAINING COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | DANA FARBER CANCER INST INC (US) | 2024-01-03 | — | — | EP | claimed |
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| CN-114106034-B | Amino acid and preparation method and application thereof | 山东达因海洋生物制药股份有限公司 | 2023-08-01 | — | — | CN | claimed |
| EP-3291676-B1 | MITRAGYNINE ANALOGS AND USES THEREOF | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-08-17 | — | — | EP | claimed |
| EP-1906945-B1 | HCV INHIBITORS | VIROBAY INC (US) | 2015-08-05 | — | — | EP | claimed |
| EP-2431379-A2 | HCV inhibitors | Virobay, Inc. (US) | 2012-03-21 | — | — | EP | claimed |
| US-20100266537-A1 | HCV INHIBITORS | VIROBAY, INC. (US) | 2010-10-21 | — | — | US | claimed |
| US-7608592-B2 | HCV inhibitors | VIROBAY, INC. (US) | 2009-10-27 | — | — | US | claimed |
| EP-1906945-A4 | HCV INHIBITORS | VIROBAY INC (US) | 2009-07-15 | — | — | EP | claimed |
| WO-2008086053-A1 | HCV INHIBITORS | VIROBAY, INC. (US) | 2008-07-17 | — | — | WO | claimed |
| US-20080161254-A1 | HCV INHIBITORS | VIROBAY, INC. (US) | 2008-07-03 | — | — | US | claimed |
| EP-1906945-A2 | HCV INHIBITORS | Virobay, Inc. (US) | 2008-04-09 | — | — | EP | claimed |
| US-20070054864-A1 | 1-[2S-(3-Tert-butylureido)-3,3-dimethylbutyryl]-4R-(7-methoxy-2-pyrazol-1-yl-quinolin-4-yloxy)-pyrrolidine-2S-carboxylic acid (1S-cyclopropylaminooxalylbutyl)amide, for example; useful in treating hepatitis C infections | QUEST DIAGNOSTICS INVESTMENTS LLC | 2007-03-08 | — | — | US | claimed |
| WO-2007005838-A2 | HCV INHIBITORS | VIROBAY, INC. (US) | 2007-01-11 | — | — | WO | claimed |